240 Infos zu Sonja Krösser

41 Aktuelle Nachrichten

Sonja Krösser, PhD, vice president of preclinical and clinical development will continue to lead NOVALIQ's dry eye developments and remains responsible for ... Sonja Krösser, PhD, vice president of preclinical and clinical development will continue to lead NOVALIQ's dry eye developments and remains responsible for ...

— Sonja Krösser, Vice President Preclinical & Clinical Development von Novaliq. „Wir sind entschlossen, eng mit der FDA zusammenzuarbeiten, um — Sonja Krösser, Vice President Preclinical & Clinical Development von Novaliq. „Wir sind entschlossen, eng mit der FDA zusammenzuarbeiten, um ...

“The initiation of this second registrational trial represents a key milestone for both CyclASol and our company,” Sonja Krösser, PhD, Vice President ... “The initiation of this second registrational trial represents a key milestone for both CyclASol and our company,” Sonja Krösser, PhD, Vice President ...

— Sonja Krösser, Vice President Medical Science and Regulatory Affairs. "Das Trockene-Auge-Syndrom ist eine ernste und schwer zu behandelnde — Sonja Krösser, Vice President Medical Science and Regulatory Affairs. "Das Trockene-Auge-Syndrom ist eine ernste und schwer zu behandelnde ...

9 Profile in Sozialen Netzwerken

StayFriends - Schulfreunde wiederfinden

Sehen Sie sich das Karriere-Profil von Sonja Krösser (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und ...

Sonja Krösser. Head Clinical Development bei Novaliq GmbH. Standort: Frankfurt am Main und ... Empfehlungen, 3 Personen haben Sonja Krösser empfohlen ... Es fehlt: entwicklungsgesellschaft ‎zollverein

Beitrag von Sonja Krösser. Profil für Sonja Krösser anzeigen · Sonja Krösser. VP Preclinical & Clinical Development bei Novaliq GmbH. 2 Monate.

6 Hobbys & Interessen

— Sonja Krösser, PhD, Vice President für präklinische und klinische Entwicklung, wird auch weiterhin die Entwicklung von Mitteln für trockene — Sonja Krösser, PhD, Vice President für präklinische und klinische Entwicklung, wird auch weiterhin die Entwicklung von Mitteln für trockene ...

— ), Sonja Krösser (Novaliq GmbH). The full article can be read at https://thehealthcaretechnologyreport.com/. About The Healthcare Technology — ), Sonja Krösser (Novaliq GmbH). The full article can be read at https://thehealthcaretechnologyreport.com/. About The Healthcare Technology ...

— ... Sonja Krösser, PhD, Vice President Medical Science and Regulatory Affairs. “DED is a serious and difficult to treat condition. Clinically — ... Sonja Krösser, PhD, Vice President Medical Science and Regulatory Affairs. “DED is a serious and difficult to treat condition. Clinically ...

— ... Sonja Krösser, PhD, Vice President Preclinical and Clinical Development bei Novaliq. „Unser Engagement für die Wissenschaft liefert die — ... Sonja Krösser, PhD, Vice President Preclinical and Clinical Development bei Novaliq. „Unser Engagement für die Wissenschaft liefert die ...

2 Firmen-Mitarbeiter

Sonja Krösser. VP Medical Science & Regulatory Affairs. Dr. Martin Mauden. Vice President Chemistry, Manufacturing & Control. Dr. Jörg Haißer. Vice President ... Sonja Krösser. VP Medical Science & Regulatory Affairs. Dr. Martin Mauden. Vice President Chemistry, Manufacturing & Control. Dr. Jörg Haißer. Vice President ...

Sonja Krösser joined Novaliq in As VP Medical Science & Regulatory Affairs she is responsible for leading development teams, progressing drug candidates ... Sonja Krösser joined Novaliq in As VP Medical Science & Regulatory Affairs she is responsible for leading development teams, progressing drug candidates ...

1 Persönliche Webseiten

Send message to Sonja Krösser. To: Sonja Krösser. Your name: Your email: Subject: Message: Dear Sonja Krösser,. Security check: What is this? [Continue].

2 Infos zur Ausbildung

Sonja Krösser · ORCID ID · Ilva D. Rupenthal · ORCID ID. Source Information. July 2023, Volume188(IssueComplete)Pages, p.100To Abstract. My Articles.

Sonja Krösser · Jason L. Vittitow. Source Information. May 2023, Volume130(Issue5)Pages, p.516To Ophthalmology · Dry Eye Disease Associated with ... Sonja Krösser · Jason L. Vittitow. Source Information. May 2023, Volume130(Issue5)Pages, p.516To Ophthalmology · Dry Eye Disease Associated with ...

4 Bücher zum Namen

· View profile for Sonja Krösser. Sonja Krösser. VP Preclinical & Clinical Development bei Novaliq GmbH. 8mo · View organization page for Review of ...

... Florian Kretz, Kathleen Kunert, Johannes Menzel-Severing, Norbert Schrage, Wolfgang Schrems, Sonja Krösser, Michael Beckert, and Elisabeth M. Messmer.

CNKI学术搜索是一个基于海量资源的跨学科、跨语种、跨文献类型的学术资源搜索平台，其资源库涵盖各类学术期刊、论文、报纸、专利、标准、年鉴、工具书等，旨在为国内外研究人员提供全面、权威、系统的知识网络。

Priyanka Agarwal ,Darina Khun ,Sonja Krösser ,Kirsten Eickhoff ,Frederick S Wells ,Geoff R Willmott ,Jennifer P Craig ,Ilva D Rupenthal. The ocular surface ... Priyanka Agarwal ,Darina Khun ,Sonja Krösser ,Kirsten Eickhoff ,Frederick S Wells ,Geoff R Willmott ,Jennifer P Craig ,Ilva D Rupenthal. The ocular surface ...

10 Dokumente

... Sonja Krösser , Michael Beckert , Claus Cursiefen , Thomas Kaercher. Publication date PMC-release: 01 October Journal: Journal of Ocular Sonja Krösser , Michael Beckert , Claus Cursiefen , Thomas Kaercher. Publication date PMC-release: 01 October Journal: Journal of Ocular ...

Philipp Eberwein Sonja Krösser , Philipp Steven , ,. Publication date (Electronic): 22 May Journal: Ophthalmic Research. Publisher: S ... Philipp Eberwein Sonja Krösser , Philipp Steven , ,. Publication date (Electronic): 22 May Journal: Ophthalmic Research. Publisher: S ...

Eur J Clin Pharmacol (2006) 62: 277–284. DOI s PHARMACOKINETICS AND DISPOSITION. Sonja Krösser.

4 Wissenschaftliche Publikationen

Inventors: Bernhard Günther, Frank Löscher, Hartmut Voss, Sonja Krösser, Kirsten Eickhoff, Daniela Willen, Markus Beier, Thomas Schlüter. SEMIFLUORINATED ... Inventors: Bernhard Günther, Frank Löscher, Hartmut Voss, Sonja Krösser, Kirsten Eickhoff, Daniela Willen, Markus Beier, Thomas Schlüter. SEMIFLUORINATED ...

von JD Sheppard · · Zitiert von: 46 — Sonja Krösser 4 , Jason L. Vittitow 5 , MOJAVE Study Group. Show more. Add to ... Epitropoulos, Sonja Krösser, Jason L. Vittitow, on behalf of the MOJAVE ... von JD Sheppard · · Zitiert von: 46 — Sonja Krösser 4 , Jason L. Vittitow 5 , MOJAVE Study Group. Show more. Add to ... Epitropoulos, Sonja Krösser, Jason L. Vittitow, on behalf of the MOJAVE ...

von J Tauber · · Zitiert von: 49 — Joseph Tauber MD 1 , Gregg J. Berdy MD 2 , David L. Wirta MD 3 , Sonja Krösser PhD 4 , Jason L. Vittitow PhD 5. GOBI Study Group ∗. Show more. Add to Mendeley. von J Tauber · · Zitiert von: 49 — Joseph Tauber MD 1 , Gregg J. Berdy MD 2 , David L. Wirta MD 3 , Sonja Krösser PhD 4 , Jason L. Vittitow PhD 5. GOBI Study Group ∗. Show more. Add to Mendeley.

9 Allgemeine Veröffentlichungen

von U Gehlsen · · Zitiert von: 36 — Sonja Krösser & … Philipp Steven. Show authors Novaliq GmbH, Heidelberg, Germany. Sonja Krösser. Authors. Uta Gehlsen. von U Gehlsen · · Zitiert von: 36 — Sonja Krösser & … Philipp Steven. Show authors Novaliq GmbH, Heidelberg, Germany. Sonja Krösser. Authors. Uta Gehlsen.

... Sonja Krösser, VP for Preclinical & Clinical Development at Novaliq. “We are committed to work[ing] closely with the FDA to bring this novel cyclosporine Sonja Krösser, VP for Preclinical & Clinical Development at Novaliq. “We are committed to work[ing] closely with the FDA to bring this novel cyclosporine ...

Sonja Krösser at Novaliq · Sonja Krösser. Novaliq. Request Full-text Paper PDF. Request full-text PDF. To read the full-text of this research, you can request a ... Sonja Krösser at Novaliq · Sonja Krösser. Novaliq. Request Full-text Paper PDF. Request full-text PDF. To read the full-text of this research, you can request a ...

Objective The 5HT1Areceptor agonist sarizotan is in clinical development for the treatment of dyskinesia, a potentially disabling complication in Parkinson’s...

1 Video- & Audioinhalte

... Sonja Krösser, PhD, VP Medical Science & Regulatory Affairs - Novaliq Moderated By: Gustavo de Moraes, MD, PhD, MPH, Chief Medical Officer ...

145 Webfunde aus dem Netz

Sonja KRÖSSER: Hartmut Voss: Frank LÖSCHER: Bernhard GÜNTHER. Worldwide applications JP. Application number: JP A. Filing date: Legal ... Sonja KRÖSSER: Hartmut Voss: Frank LÖSCHER: Bernhard GÜNTHER. Worldwide applications JP. Application number: JP A. Filing date: Legal ...

— Sonja KRÖSSER: Thomas SCHLÜTER: Alice MEIDES; Current Assignee. The listed assignees may be inaccurate. Google has not performed a legal — Sonja KRÖSSER: Thomas SCHLÜTER: Alice MEIDES; Current Assignee. The listed assignees may be inaccurate. Google has not performed a legal ...

Sonja Krösser attended Heidelberg University. What are some of Sonja Krösser's skills? Sonja Krösser has skills like Clinical Pharmacology, Pharmacokinetics, ... Sonja Krösser attended Heidelberg University. What are some of Sonja Krösser's skills? Sonja Krösser has skills like Clinical Pharmacology, Pharmacokinetics, ...

Firmenbekanntmachungen und Netzwerk zu Sonja Krösser, Heidelberg: NOVALIQ GmbH. Firmenbekanntmachungen und Netzwerk zu Sonja Krösser, Heidelberg: NOVALIQ GmbH.

Articles by Sonja Krösser on Muck Rack. Find Sonja Krösser's email address, contact information, LinkedIn, Twitter, other social media and more. Articles by Sonja Krösser on Muck Rack. Find Sonja Krösser's email address, contact information, LinkedIn, Twitter, other social media and more.

Dr. Sonja Krösser joined Novaliq in In her current role as VP Preclinical and Clinical Development she is responsible for leading development teams, ... Dr. Sonja Krösser joined Novaliq in In her current role as VP Preclinical and Clinical Development she is responsible for leading development teams, ...

Bernhard Günther, Dossenheim (DE); Frank Löscher, Schriesheim (DE); Hartmut Voss, Schriesheim (DE); Sonja Krösser, Heidelberg (DE); Kirsten Eickhoff ... Bernhard Günther, Dossenheim (DE); Frank Löscher, Schriesheim (DE); Hartmut Voss, Schriesheim (DE); Sonja Krösser, Heidelberg (DE); Kirsten Eickhoff ...

von JD Sheppard · · Zitiert von: 38 — Sonja Krösser. ‖Novaliq GmbH, Heidelberg, Germany;. Find articles by Sonja Krösser. Author information Article notes Copyright and License information ... von JD Sheppard · · Zitiert von: 38 — Sonja Krösser. ‖Novaliq GmbH, Heidelberg, Germany;. Find articles by Sonja Krösser. Author information Article notes Copyright and License information ...

... Sonja Krösser, Ruxia Xu, Jing Hong · DOI: jamaophthalmol Multinational External Validation of Autonomous Retinopathy of Prematurity Sonja Krösser, Ruxia Xu, Jing Hong · DOI: jamaophthalmol Multinational External Validation of Autonomous Retinopathy of Prematurity ...

Authors: Uta Gehlsen, Tobias Braun, Maria Notara, Sonja Krösser, Philipp Steven. Funder Novaliq GmbH. List of references. Stern ME, Schaumburg CS, Pflugfelder ... Authors: Uta Gehlsen, Tobias Braun, Maria Notara, Sonja Krösser, Philipp Steven. Funder Novaliq GmbH. List of references. Stern ME, Schaumburg CS, Pflugfelder ...

Christian Roesky's colleagues are Madlen Witt, Markus Beier, Anja Sticher, Patricia Retzlik, Kirsten Fischer, Sonja Krösser, and Mikhail Barkovskiy. Who are ... Christian Roesky's colleagues are Madlen Witt, Markus Beier, Anja Sticher, Patricia Retzlik, Kirsten Fischer, Sonja Krösser, and Mikhail Barkovskiy. Who are ...

Carol A Aune, Patrick M Vollmer, Alice S Meides, Sonja Krösser, David L Wirta, Anat Galor, Eva Liang> ;Cornea May 21; 1 citations. Omidenepag Isopropyl ... Carol A Aune, Patrick M Vollmer, Alice S Meides, Sonja Krösser, David L Wirta, Anat Galor, Eva Liang> ;Cornea May 21; 1 citations. Omidenepag Isopropyl ...

... Sonja Krösser, PhD, Vice President Medical Science and Regulatory Affairs. “DED is a serious and difficult to treat condition. Clinically meaningful Sonja Krösser, PhD, Vice President Medical Science and Regulatory Affairs. “DED is a serious and difficult to treat condition. Clinically meaningful ...

Ousler, Philipp Steven, MD, Sonja Krösser, PhD. Ophthalmology. Volume 126 Issue 6 Pages (June 2019). DOI: j.ophtha Copyright © Ousler, Philipp Steven, MD, Sonja Krösser, PhD. Ophthalmology. Volume 126 Issue 6 Pages (June 2019). DOI: j.ophtha Copyright ©

Galor +4 authors. Sonja Krösser. Medicine. Cornea TLDR. The results demonstrated sustained 1-year efficacy, in both signs and symptoms of DED, and may ... Galor +4 authors. Sonja Krösser. Medicine. Cornea TLDR. The results demonstrated sustained 1-year efficacy, in both signs and symptoms of DED, and may ...

von JD Sheppard · · Zitiert von: 6 — John D Sheppard, Fred K Kurata, Alice Epitropoulos, Sonja Krösser, Jason Vittitow; Efficacy of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye ... von JD Sheppard · · Zitiert von: 6 — John D Sheppard, Fred K Kurata, Alice Epitropoulos, Sonja Krösser, Jason Vittitow; Efficacy of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye ...

Sheppard, Adam Hamm, Simone Angstmann-Mehr, Sonja Krösser. School of Medicine. Research output: Contribution to journal › Review article › peer-review. Sheppard, Adam Hamm, Simone Angstmann-Mehr, Sonja Krösser. School of Medicine. Research output: Contribution to journal › Review article › peer-review.

Sonja Krösser. Abstract. Purpose: The ESSENCE-2 Open-Label Extension study aimed to demonstrate long-term safety, tolerability, and efficacy of a ... Sonja Krösser. Abstract. Purpose: The ESSENCE-2 Open-Label Extension study aimed to demonstrate long-term safety, tolerability, and efficacy of a ...

von V Jung · · Zitiert von: 2 — Sonja Krösser , Gabriela Burian , Ralf Grillenberger , Johannes Korward , Christian Roesky. Affiliations. 1 Novaliq GmbH Heidelberg ... von V Jung · · Zitiert von: 2 — Sonja Krösser , Gabriela Burian , Ralf Grillenberger , Johannes Korward , Christian Roesky. Affiliations. 1 Novaliq GmbH Heidelberg ...

Sonja Krösser et al. European journal of clinical pharmacology, 62(4), ( ). The 5HT(1A) receptor agonist sarizotan is in ... Sonja Krösser et al. European journal of clinical pharmacology, 62(4), ( ). The 5HT(1A) receptor agonist sarizotan is in ...